US Patent Issued to Takeda Pharmaceutical on July 8 for "Process for producing 5-aryl-1H-pyrolle-3-carbonitrile compounds by dehalogenation" (Japanese Inventors)

ALEXANDRIA, Va., July 9 -- United States Patent no. 12,351,553, issued on July 8, was assigned to Takeda Pharmaceutical Co. Ltd. (Osaka, Japan).

"Process for producing 5-aryl-1H-pyrolle-3-carbonitrile compounds by dehalogenation" was invented by Tomomi Ikemoto (Osaka, Japan), Toshiaki Nagata (Osaka, Japan), Misayo Sera (Osaka, Japan) and Naohiro Fukuda (Osaka, Japan).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention provides a production method for 5-Aryl-1H-Pyrolle-3-Carbontirile compounds:The productions method provides key intermediates useful for a method of preparing additional pyrrole compounds useful as a pharmaceutical product, particularly an acid secretion inhibitor, a productions...